Sylvester Comprehensive Cancer Center

E-mail a Friend

Alessia Fornoni, M.D., Ph.D.

General Information

Alessia  Fornoni, M.D., Ph.D.

Languages

  • English
  • Italian

Certifications

  • American Board of Internal Medicine
  • American Board of Internal Med-Nephrology

CV

Specialties

  • Nephrology - Internal Medicine
  • Internal Medicine

Roles

  • Associate Professor of Medicine

Clinical Interests

Diabetic nephropathy, glomerular diseases, inherited nephropathies, chronic kidney disease

Research Interests

  • Biology of the podocyte
  • Biology of pancreatic beta cells in diabetes
  • Personalized Nephrology
  • Therapeutic strategies for diabetes and chronic kidney diseases
  • Experimental Therapeutics

Awards

Scientific Award Committee
Scientific Award Committee
Professional Development Course, American Society of Nephrology
Stanley Glaser Award
Amgen junior faculty award
Stanley J. Glaser Foundation Biomedical Research Award
Professional development seminar award

Education

2000 Ph.D.
Universita' degli Studi di Pavia
1995 M.D.
Universita' degli Studi di Pavia

Publications

Biography

Dr Fornoni obtained her MD and her PhD degree in Medical Pharmacology at the Universita' degli Studi di Pavia (Italy). She later joined the laboratory of Renal Cell Biology (Vascular Biology Institute) at the University of Miami, where she worked on animal models of diabetic nephropathy and on the role of mesangial stem cells progenitors under the direct supervision of Drs Liliane and Gary Striker. After her post-doctoral fellowship, Dr Fornoni completed the Internal Medicine and Nephrology training at the University of Miami (Basic Scientist Investigator pathway). She is Board Certified in both Internal Medicine and Nephrology. She currently devotes 75% of her time to research and 25% to patient care. Dr Fornoni research interest is focus on diabetes, with particular interest in diabetic nephropathy and pancreatic islets function in both type 1 and type 2 diabetes. Dr Fornoni research resulted in the finding that glucose may irreversibly affect the phenotype of glomerular mesangial cells, mainly through direct alteration of unstable regions of genomic DNA. Dr Fornoni is currently interested in the intracellular signaling pathways activated in islets and podocytes by inflammation. Dr. Fornoni research goal is to translate her basic science findings into clinical research through the identification of new therapeutic targets for the improvement of diabetes and its complications.

E-mail a Friend